“Consumers who try to buy popular weight loss drugs online without a prescription risk being scammed or receiving unsafe products, a new study shows,” Liz Szabo writes over at NBC News. “About 42% of online pharmacies that sell semaglutide, the active ingredient in Novo Nordisk’s anti-obesity drug Wegovy, are illegal, operating without a valid license and selling medications without prescriptions, according to a study published Friday in JAMA Network Open. People who shop online for weight loss drugs ‘face serious consumer risks’ of receiving ‘ineffective and dangerous products,’ said Tim Mackey, an author of the report and professor of global health at the University of California, San Diego, as well as the director of the Global Health Policy and Data Institute. The study also included researchers from University of Pecs in Hungary. Shortages of the popular weight loss medication, which belongs to a class of drugs called GLP-1s, have led to ‘a black market of illegal knockoffs,’ said Dr. Christopher McGowan, the founder, medical director and research director of True You Weight Loss, a weight loss clinic in Cary, North Carolina. ‘This is absolutely terrifying,’ said McGowan, who wasn’t involved with the research. Illegal pharmacies are ‘exposing patients to risks related to unregulated, low-quality, potentially contaminated products. The average person cannot be expected to safely navigate this online medication minefield, which is why it’s best to stick to brand-name, FDA-authorized medications,’ he said. .. On its website, Novo Nordisk says patients can spot counterfeit medications by looking for certain telltale signs, such as packages with spelling errors or which are unsealed, or prices that seem too good to be true. … ‘If a pharmacy doesn’t require a prescription, a medical consultation or any understanding of your health, it’s not legitimate,’ McGowan said.” Liz Szabo, “Nearly half of online pharmacies selling weight loss drugs are operating illegally, study finds,” NBC News.
Jeanne Pinder is the founder and CEO of ClearHealthCosts. She worked at The New York Times for almost 25 years as a reporter, editor and human resources executive, then volunteered for a buyout and founded... More by Jeanne Pinder
